Patent lawyers explain why they will be keeping an eye on the implications of a pharma case and on changes at the USPTO in ...

If we’re serious about keeping pace with China, we must restore the legal foundations that once made America the global leader in high-tech innovation. That means passing legislation like the ...

Thorough IP due diligence can determine not just the success of a transaction but your company's future market position.

In our latest interview with women IP leaders, Catherine Bonner at Murgitroyd discusses technology, training, and teaching ...

The PTAB statistics through the first half of FY2025 translate to an all-claims invalidation rate of 64%—a drop from 70% in ...

Tech companies are embracing an unorthodox appellate procedure to challenge policy shifts expanding the US Patent and ...

On Monday, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential ruling in Eye Therapies, LLC v.

Each rose developed by David Austin can take up to 12 years from the initial cross to commercial release. The business’s IP ...